Leponex orally disintegrating tablet and preparation method thereof

A technology of orally disintegrating tablets and clozapine, which is applied in the technical field of improving oral preparations of clozapine, can solve problems such as low dissolution rate, slow disintegration speed, and non-recording

Inactive Publication Date: 2006-07-26
马晶
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The currently clinically used oral preparation of clozapine is clozapine tablet, and its bioavailability is low, which is related to its slow disintegration speed and low dissolution rate.
[0004] Orally

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Leponex orally disintegrating tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Clozapine 100.0g

[0043] Sodium carboxymethyl starch 14.0g

[0044] Microcrystalline Cellulose 60.0g

[0045] Micronized silica gel 5.0g

[0046] Aspartame 0.5g

[0047] Magnesium stearate 0.9g

[0048] Made into 1000 pieces

[0049] Clozapine, microcrystalline cellulose, sodium carboxymethyl starch, micropowder silica gel, and magnesium stearate were all passed through a 100-mesh sieve.

[0050] Weigh 100.0 grams of clozapine, first mix with 14.0 grams of sodium carboxymethyl starch in equal increments, then add 60.0 grams of microcrystalline cellulose and mix thoroughly, then mix with 5.0 grams of micropowder silica gel, 0.5 grams of aspartame Sweetened and mixed with 0.9 g of magnesium stearate. Detect the percentage content of clozapine in the mixed powder, calculate the weight of the tablet, and press it into a tablet. In this way, 1000 orally disintegrating tablets of clozapine can be compressed.

[0051] Its disintegration t...

Embodiment 2

[0053] Clozapine 85.0g

[0054] Sodium carboxymethyl starch 10.3g

[0055] Microcrystalline Cellulose 55.8g

[0056] Micronized silica gel 3.9g

[0057] Aspartame 0.3g

[0058] Magnesium Stearate 2.7g

[0059] Made into 1000 pieces

[0060] Clozapine, microcrystalline cellulose, sodium carboxymethyl starch, micropowder silica gel, and magnesium stearate were all passed through a 100-mesh sieve.

[0061] Weigh 85.0 grams of clozapine, first mix it with 10.3 grams of sodium carboxymethyl starch in equal increments, then add 55.8 grams of microcrystalline cellulose and mix thoroughly, then add 3.9 grams of micropowder silica gel, 0.3 aspartame Mix with 2.7 grams of magnesium stearate. Detect the percentage content of clozapine in the mixed powder, calculate the weight of the tablet, and press it into a tablet. In this way, 1000 orally disintegrating tablets of clozapine can be compressed.

[0062] Its disintegration time is 32 seconds, ...

Embodiment 3

[0064] Clozapine 87.0g

[0065] Sodium carboxymethyl starch 7.3g

[0066] Microcrystalline Cellulose 47.6g

[0067] Micronized silica gel 2.9g

[0068] Aspartame 0.1g

[0069] Magnesium stearate 0.1g

[0070] Made into 1000 pieces

[0071] Clozapine, microcrystalline cellulose, sodium carboxymethyl starch, magnesium stearate, and micropowder silica gel were all passed through a 100-mesh sieve.

[0072] Weigh 87.0 grams of clozapine, first mix with 7.3 grams of sodium carboxymethyl starch in an equal amount, then add 47.6 grams of microcrystalline cellulose and mix thoroughly, then successively 2.9 grams of micropowder silica gel, 0.1 grams of aspartame Mix with 0.1 gram of magnesium stearate. Detect the percentage content of clozapine in the mixed powder, calculate the weight of the tablet, and press it into a tablet. In this way, 1000 orally disintegrating tablets of clozapine can be compressed.

[0073] Its disintegration time ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a clozapine oral disintegrating tablet, which is prepared from 50.0-60.0 wt% of clozapine, 5.0-10.0.0wt% of sodium carboxymethylstarch, 30.0-40.0.0wt% of crystalline cellulose, 2.0-5.0wt% of miropowdered silica gel, 0.1-2.0wt% of magnesium stearate and 0.1-0.5 wt% of Aspartame through disintegrating and passing through 100 mesh sieve, mixing homogeneously, and carrying out powder direct pelleting method to obtain the composition.

Description

Technical field: [0001] The invention relates to a pharmaceutical composition containing clozapine, and relates to an improved technique for oral preparations of clozapine. technical background: [0002] Clozapine is an atypical antipsychotic drug, which has been widely used clinically since it was put on the market in the 1970s. It is effective for both positive and negative symptoms of schizophrenia, especially treatment-resistant schizophrenia. It is better for patients' social adaptability, quality of life and employment potential. It is the only drug found so far that can improve cognitive function, especially in language memory. It is not only suitable for the treatment of the acute phase of schizophrenia, but also for the long-term maintenance treatment. In addition, it is also used in the treatment of mental disorders caused by other diseases. In recent years, Clozapine has also been used to reduce suicidal tendencies in patients with schizophrenia. Clozapine can ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/551A61K9/20A61P25/18
CPCA61K31/5513
Inventor 马晶
Owner 马晶
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap